Fierce Health Payers June 25, 2020
Paige Minemyer

Not even the coronavirus pandemic—and the economic losses that have accompanied it—could lower drug prices, according to a new analysis.

Researchers at GoodRx, which offers discounts and coupons on prescriptions, found drug prices have only declined by 0.6% since February, according to data provided exclusively to Fierce Healthcare. In addition, drugmakers are expected to increase prices on July 1.

Meanwhile, COVID-19 has had an impact on prices in a number of other product lines over the past several months, according to the report. For example, prices for transportation fell by 33% between February and May, and prices for clothing and telephone services were also down.

Tori Marsh, a member of GoodRx’s research team, told Fierce Healthcare that prescription drug prices...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Pharma / Biotech, Pricing / Spending, Public Health / COVID
How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?
Podcast #1: Doing Digital Deals in Life Sciences | Corporate Culture

Share This Article